scispace - formally typeset
Search or ask a question
Institution

Montreal Children's Hospital

HealthcareMontreal, Quebec, Canada
About: Montreal Children's Hospital is a healthcare organization based out in Montreal, Quebec, Canada. It is known for research contribution in the topics: Population & Poison control. The organization has 3842 authors who have published 4816 publications receiving 200198 citations.
Topics: Population, Poison control, Gene, Medicine, Kidney


Papers
More filters
Journal ArticleDOI
TL;DR: The prevalence of moderate to severe sleep‐disordered breathing in patients with myelomeningocele may be as high as 20%, but little information is available regarding treatment of these patients.
Abstract: The prevalence of moderate to severe sleep-disordered breathing (SDB) in patients with myelomeningocele may be as high as 20%, but little information is available regarding treatment of these patients. To assess the efficacy and complications of treatments for these children, we collected data on 73 patients from seven pediatric sleep laboratories. Obstructive sleep apnea (OSA, n = 30) and central apnea (n = 25) occurred more frequently than central hypoventilation (n = 12). We also describe a sleep-exacerbated restrictive lung disease type of SDB in 6 patients who had hypoxemia during sleep without apnea or central hypoventilation. For each type of SDB, effective treatments were identified in a stepwise process, moving towards more complex and invasive therapies. For OSA, adenotonsillectomy was often ineffective (10/14), whereas nasal continuous positive airway pressure (CPAP) was usually successful (18/21). For central apnea, methylxanthines and/or supplemental oxygen proved sufficient in 2 of 9 and 3 of 6, respectively, but noninvasive positive pressure ventilation was required in 7 children. For central hypoventilation, supplemental oxygen (alone or with methylxanthines), noninvasive positive pressure ventilation, and tracheostomy with positive pressure ventilation were effective in 3, 2, and 2 patients, respectively. Sleep-exacerbated restrictive lung disease always required supplemental oxygen treatment, but in 2 cases also required noninvasive positive pressure ventilation; nutritional and orthopedic procedures also were helpful. Posterior fossa decompression was used for the first three types of SDB, but data were insufficient to delineate specific recommendations for or against its use. In summary, evaluation by an experienced, multidisciplinary team can establish an effective treatment regime for a child with myelomeningocele and SDB.

65 citations

Journal ArticleDOI
TL;DR: The view that glucocorticoids affect lung cell maturation in a manner comparable to the interaction of other steroid hormones with their target tissues is supported.
Abstract: Fetal lung cells from 28 day gestation rabbits cultured in the presence of cortisol (5.5 ×10−6M), corticosterone (5.5 × 10−6M) or dexamethasone (5.5 × 10−8M) incorporated [3H]choline into lecithin to a significantly greater extent than did control cultures. 11-Deoxycortisol, 21-deoxycortisol and ll)βhydroxyprogesi:erone, at a concentration of 5.5 × 10−5M, had no effect on lecithin synthesis. However, when lung cells were simultaneously exposed to these sterofds and to cortisol at the concentrations quoted, [3H]choline incorporation was reduced to control values. Cortisone (5.5 × 10−6M) also enhanced lecithin synthesis, the activity of the steroid likely being related to the capacity of the lung cells to convert cortisone to cortisol. This hypothesis was supported by the observations that 11-ketoprogesterone (1.3 × 10−5M), which totally inhibited the conversion of cortisone to cortisol and which had no effect of its own on [3H]choline incorporation, inhibited the effect of cortisone on lecithin synthesis b...

65 citations

Journal ArticleDOI
TL;DR: The types and possible risk factors associated with the development of sleep problems in children with cerebral palsy and the impact of this disorder on the child and family are explored.
Abstract: Children with neurodevelopmental disabilities, such as cerebral palsy, are considered to be a population at risk for the occurrence of sleep problems Moreover, recent studies on children with cerebral palsy seem to indicate that this population is at higher risk for sleep disorders The importance of the recognition and treatment of sleep problems in children with cerebral palsy cannot be overemphasized It is well known that the consequences of sleep disorders in children are broad and affect both the child and family This review article explores the types and possible risk factors associated with the development of sleep problems in children with cerebral palsy and the impact of this disorder on the child and family In addition, a brief summary of current diagnostic and treatment modalities is provided Finally, the characteristics, diagnostic techniques, and management of sleep-related breathing disorders in children with cerebral palsy are discussed

65 citations

Journal ArticleDOI
15 Nov 1994-Genomics
TL;DR: A cDNA encoding the human precursor for a novel member (gene symbol ACADSB) of the ACD gene family has been isolated and characterized, producing a protein of the expected size.

65 citations

Journal ArticleDOI
TL;DR: In pediatric AML, infection, sepsis, and infectious death were associated with duration of corticosteroid exposure, and Corticosteroids should be avoided when possible for this population.
Abstract: Background Infection continues to be a major problem for children with acute myeloid leukemia (AML). Objectives were to identify factors associated with infection, sepsis, and infectious deaths in children with newly diagnosed AML. Methods We conducted a retrospective, population-based cohort study that included children ≤ 18 years of age with de novo, non-M3 AML diagnosed between January 1995 and December 2004, treated at 15 Canadian centers. Patients were monitored for infection from initiation of AML treatment until recovery from the last cycle of chemotherapy, conditioning for hematopoietic stem cell transplantation, relapse, persistent disease, or death (whichever occurred first). Consistent trained research associates abstracted all information from each site. Results 341 patients were included. Median age was 7.1 years (interquartile range [IQR], 2.0-13.5) and 29 (8.5%) had Down syndrome. In sum, 26 (7.6%) experienced death as a first event. There were 1277 courses of chemotherapy administered in which sterile site microbiologically documented infection occurred in 313 courses (24.5%). Sepsis and infectious death occurred in 97 (7.6%) and 16 (1.3%) courses, respectively. The median days of corticosteroid administration was 2 per course (IQR, 0-6). In multiple regression analysis, duration of corticosteroid exposure was significantly associated with more microbiologically documented sterile site infection, bacteremia, fungal infection, and sepsis. The only factor significantly associated with infectious death was days of corticosteroid exposure (odds ratio, 1.05; 95% confidence interval, 1.02-1.08; P = .001). Conclusions In pediatric AML, infection, sepsis, and infectious death were associated with duration of corticosteroid exposure. Corticosteroids should be avoided when possible for this population.

65 citations


Authors

Showing all 3844 results

NameH-indexPapersCitations
Paul M. Matthews14061788802
Joost J. Oppenheim13045459601
Michael Camilleri125108458867
James M. Swanson11741547131
Rhian M. Touyz11462043738
Ian Roberts11271451933
William D. Foulkes10868245013
Stephen P. Hinshaw10633037336
Michael S. Kramer10456843803
Liam Smeeth10475353433
Eric Fombonne10033644447
Douglas L. Arnold10062437040
Erwin W. Gelfand9967536059
Frederick Andermann9036525638
Robert W. Platt8863831918
Network Information
Related Institutions (5)
Boston Children's Hospital
215.5K papers, 6.8M citations

95% related

Baylor College of Medicine
94.8K papers, 5M citations

92% related

Medical College of Wisconsin
41.5K papers, 1.7M citations

91% related

Medical University of South Carolina
45.4K papers, 1.7M citations

91% related

University of Texas Health Science Center at Houston
42.5K papers, 2.1M citations

90% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20232
202214
2021169
2020134
2019120
2018125